Ποια είναι η τιμή για Arch Biopartners Inc. (ARCH)

Η τιμή για Arch Biopartners Inc. (ARCH) είναι $0.73393689

Ποια είναι η κεφαλαιοποίηση αγοράς για Arch Biopartners Inc. (ARCH)

Η κεφαλαιοποίηση αγοράς για Arch Biopartners Inc. (ARCH) είναι $49.86M

Arch Biopartners Inc. (ARCH) Κέρδη ανά Μετοχή

Arch Biopartners Inc. is a biotechnology firm dedicated to devising groundbreaking solutions for both medical and commercial applications. A significant focus for the company is the advancement of Metablok, a key therapeutic agent designed to address or avert dipeptidase-1 driven inflammation in critical organs such as the lungs, liver, and kidneys. This inflammatory response can lead to profound organ dysfunction or complete failure, particularly in conditions like sepsis and COVID-19. Moreover, Arch Biopartners is developing AB569, an experimental medication intended to combat antibiotic-resistant bacterial infections, primarily through topical application on wounds. Their innovative product pipeline also features Borg, a specialized peptide-solid surface interface developed to hinder biofilm formation and lessen material corrosion. Lastly, MetaMx involves synthetic compounds engineered to target the cells that initiate brain tumors and invasive glioma cells. The company's operations are based out of Toronto, Canada.

Έτος	EPS	Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Έτος

EPS

Αλλαγή

Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Εταιρεία	EPS	Διαφορά EPS	Χώρα
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-	US
Argenx SE ARGX.US	$27.74	-	NL
CSL Limited CSL.AX	$2.98	-	AU
Lonza Group AG LONN.SW	-	-	CH
Moderna, Inc. MRNA.US	$-7.98	-	US

Εταιρεία

EPS

Διαφορά EPS

Χώρα